Fundraising FoxProto Axiom
Venture studioSydney · Pre-Seed–Seed · 28 people tracked
Find your way into Proto Axiom
Sign up to see every warm intro you have to Proto Axiom
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Proto Axiom team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Proto Axiom operates as a venture studio, building the companies it invests in rather than solely backing external founders. Based in Sydney and established in 2021, the firm centers its work on Australian science combined with what it describes as pharma-grade execution. Its associated initiatives, including a Challenger Summit and a Women's Health Foundry, suggest a focus on science-driven, health-related company creation.
Source: firm website, verified Aug 3, 2026.
Team · 28 people
from the firm's website
Founder mafia
2 people who came through Proto Axiom went on to found or lead other companies.
What they invest in
from 4 of 9 portfolio companiesBiotech ×3Deep Tech ×2Healthtech ×2Medical Devices ×1New Materials ×1
HQs:United States×2Australia×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2026 · 12017 · 12 dated
AdvanCell is a clinical-stage radiopharmaceutical company developing a pipeline of targeted alpha therapies for the treatment of cancers including prostate, melanoma, ovarian, breast, and lung.
BiotechHealthtechMedical DevicesCambridge, US
Andrew Adamovich(Director)inPhilina Lee(Executive Officer, Director)inAaron Pickett(Executive Officer)in
BoardWing Cheong Lam(Director)Nik Economopoulos(Director)Anthony Aiudi(Director)
Co-investorsBain Capital Life SciencesCatalio Capital Management, LPSanofi VenturesSV Health InvestorsTenmileAbingworth+2 more
Floaxiom develops NanoSurface, a biologically manufactured affinity nanoparticle platform for antibody (mAb) purification, offering a chromatography-free alternative to protein A resin columns and membrane systems.
BiotechDeep TechNew Materials
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Amazing GutCellutechEndo AxiomHerikinJumpStart FertilityOnyx AxiomSWAN Genomics
Portfolio news
latest coverage across their companies
AdvanCell Isotopes · intelligence360.news · Aug 4, 2026
Frequently asked questions
- How many investments has Proto Axiom made?
- Proto Axiom has 9 tracked investments, including 1 dated in the last 24 months.
- What stage does Proto Axiom invest at?
- Proto Axiom invests at the Pre-Seed, Seed stages.
- What sectors does Proto Axiom focus on?
- Proto Axiom focuses on Biotech, Deep Tech, FemTech, Healthtech, Medical Devices.
- Where is Proto Axiom located?
- Proto Axiom is headquartered in Sydney, AU.
- Does Proto Axiom lead rounds?
- Yes, Proto Axiom leads investment rounds.
- Who does Proto Axiom co-invest with?
- Proto Axiom most often shares deals with Bain Capital Life Sciences, Catalio Capital Management, LP, Sanofi Ventures, among 5 tracked co-investors.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Industrifonden is a Sweden-based venture capital fund investing in scalable, science- and technology-driven ventures across the Nordics.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
General Inception (GI) partners with technical and scientific founders to co-found and build deep tech, science-based startups, providing people, customers, funding connections, and operational support from idea through seed investment and scaling.
Forepont Capital Partners is a venture capital firm founded in 2017 and headquartered in New York, investing in early-stage companies with potential for large-scale impact.